Last reviewed · How we verify
NCT06796205
Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure.
trial testing Treated zones exposed with Visible Light source in Visible Light Exposure on Healthy Back Skin in 20 participants. Completed in 16 July 2021.
16 July 2021
Quick facts
| Lead sponsor | Cosmetique Active International |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 9 June 2021 |
| Primary completion | 16 July 2021 |
| Estimated completion | 16 July 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Treated zones exposed with Visible Light source
- Untreated zone exposed with Visible Light source
Conditions studied
- Visible Light Exposure on Healthy Back Skin — all drugs for Visible Light Exposure on Healthy Back Skin →
Sponsor
Cosmetique Active International — full company profile →
Who can join
Adults 18 to 50, any sex, with Visible Light Exposure on Healthy Back Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the protective effect of three sunscreens products on the pigmentation caused by visible light in comparison to an untreated control zone in healthy volunteers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Visible Light-Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment.
Renoux P, Jouni H, Laloux C, Touti R, et al · · 2025 · cited 3× · PMID 40922539 · DOI 10.1111/exd.70167
Verify or expand the search:
- PubMed search for NCT06796205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cosmetique Active International trials
Trials by the same sponsor.
- NCT07239726 — CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPI · NA · not yet recruiting
- NCT06590779 — Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss · NA · not yet recruiting
- NCT06516224 — Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma · NA · not yet recruiting
- NCT07537595 — Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) [400-450nm] · completed
- NCT06320314 — Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06796205 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cosmetique Active International
- Last refreshed: 28 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06796205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing